checkAd

     401  0 Kommentare Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024 - Seite 2

    CONTACTS
    Iovance Biotherapeutics, Inc:
    Sara Pellegrino, IRC
    Senior Vice President, Investor Relations & Corporate Communications
    650-260-7120 ext. 264
    Sara.Pellegrino@iovance.com

    Lesen Sie auch

    Jen Saunders
    Senior Director, Investor Relations & Corporate Communications
    267-485-3119
    Jen.Saunders@iovance.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2
    Verfasst von globenewswire
    Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024 - Seite 2 SAN CARLOS, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) - Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for …